Senior Commercial Executive - Biopharma | Principal Owner | Marketing, Sales, & Operations Subject Matter Expert | Advisor | Coach
I am putting together a presentation titled “The Link Between Science & Commercial Strategy for Pre-IPO Pharma Success.” One of the suggested slides is on the topic of best practices early companies engage in to overcome common pitfalls in their pursuit of success. Some of the successful behaviors I listed include - 📈 Understanding how innovation will translate into market success. Great science does not guarantee commercial success. ⚠️ Factoring the technical risk of FDA approval into strategic planning. Too often, companies miss key information the FDA is communicating. 🔂 Developing key strategies early based on commercial analytics. Commercial represents a lot more than just sales and marketing. ⚙️ Having the tools and processes for considering a wide variety of strategic options and risks. All too often companies treat forecasts as number generators vs. strategy assessment tools. Speed to market is rarely a winning strategy. 🗣 Creating dialogue between commercial and clinical leads. A lack of organizational alignment is detrimental to corporate success. Now it’s your turn! Let's start a conversation and learn from each other as we navigate the challenges and opportunities that come with bringing innovative therapies to market. Share your thoughts and experiences in the comments below and let's collaborate for pre-IPO pharma success. #IlluminationStrategyGroup #PharmaInnovation #Teamwork